Genome‐wide association study of N370S homozygous Gaucher disease reveals the candidacy of CLN8 gene as a genetic modifier contributing to extreme phenotypic variation
Open Access
- 19 January 2012
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 87 (4), 377-383
- https://doi.org/10.1002/ajh.23118
Abstract
Mutations in GBA1 gene result in defective acid β‐glucosidase and the complex phenotype of Gaucher disease (GD) related to the accumulation of glucosylceramide‐laden macrophages. The phenotype is highly variable even among patients harboring identical GBA1 mutations. We hypothesize that modifier gene(s) underlie phenotypic diversity in GD and performed a GWAS study in Ashkenazi Jewish patients with type 1 GD (GD1), homozygous for N370S mutation. Patients were assigned to mild, moderate, or severe disease categories using composite disease severity scoring systems. Whole‐genome genotyping for >500,000 SNPs was performed to search for association signals using OQLS algorithm in 139 eligible patients. Several SNPs in linkage disequilibrium within the CLN8 gene locus were associated with the GD1 severity: SNP rs11986414 was associated with GD1 severity at P value 1.26 × 10−6. Compared to mild disease, risk allele A at rs11986414 conferred an odds ratio of 3.72 for moderate/severe disease. Loss of function mutations in CLN8 causes neuronal ceroid‐lipofuscinosis, but our results indicate that its increased expression may protect against severe GD1. In cultured skin fibroblasts, the relative expression of CLN8 was higher in mild GD compared to severely affected patients, in whom CLN8 risk alleles were overrepresented. In an in vitro cell model of GD, CLN8 expression was increased, which was further enhanced in the presence of bioactive substrate, glucosylsphingosine. Taken together, CLN8 is a candidate modifier gene for GD1 that may function as a protective sphingolipid sensor and/or in glycosphingolipid trafficking. Future studies should explore the role of CLN8 in pathophysiology of GD. Am. J. Hematol., 2012.This publication has 55 references indexed in Scilit:
- Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodiesJournal of Inherited Metabolic Disease, 2011
- A monozygotic twin pair with highly discordant Gaucher phenotypesBlood Cells, Molecules, and Diseases, 2011
- Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophageProceedings of the National Academy of Sciences of the United States of America, 2010
- A reappraisal of Gaucher disease—diagnosis and disease management algorithmsAmerican Journal of Hematology, 2010
- ACTH protects against glucocorticoid-induced osteonecrosis of boneProceedings of the National Academy of Sciences of the United States of America, 2010
- Acid β-Glucosidase 1 Counteracts p38δ-dependent Induction of Interleukin-6Online Journal of Public Health Informatics, 2009
- Case‐control association testing in the presence of unknown relationshipsGenetic Epidemiology, 2009
- The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patientsAmerican Journal of Hematology, 2009
- Effective cell and gene therapy in a murine model of Gaucher diseaseProceedings of the National Academy of Sciences of the United States of America, 2006
- A gene atlas of the mouse and human protein-encoding transcriptomesProceedings of the National Academy of Sciences of the United States of America, 2004